In mice with sepsis, SS31 prevented the fall in diaphragm force generation.
In plain wordsIn mice with sepsis, SS31 prevented the loss of diaphragm muscle force that sepsis caused.
- Peptide
- Elamipretide (SS-31)
- Outcome
- IncreaseDiaphragm specific force (muscle-field stimulation)
- Study
mousen: not reported in source
Sepsis by cecal ligation puncture (CLP)- Comparator
- CLP
- Outcome group
- Exercise and physical function · Respiratory
- Studied dose
- 10 mg/kg/dayAs given in this study (mouse).
Measurements
- Diaphragm specific force
- 27.9 N/cm2
- CLP+SS31
- Diaphragm specific force
- 9.4 N/cm2
- CLP
Source sentences
Diaphragm-specific force generation averaged 30.2 ± 1.4, 9.4 ± 1.8, 25.5 ± 2.3, and 27.9 ± 0.6 N/cm2 for sham, CLP, sham+SS31, and CLP+SS31 groups (P < 0.001).
2 context sentences(design, population, supporting numbers)
Sepsis markedly reduced diaphragm force generation; SS31 prevented these decrements.
Four groups of mice were studied: 1) sham-operated controls, 2) sham-operated+SS31 (10 mg·kg-1·day-1), 3) cecal ligation puncture (CLP), and 4) CLP+SS31.